title: Central retinal vein occlusion and subsequent neovascular glaucoma after adalimumab treatment for psoriasis.
authors.affiliation: Department of Dermatology, National Cheng Kung University College of Medicine and Hospital, Tainan City, Taiwan; Institute of Clinical Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan City, Taiwan.
authors.forename: C-K
authors.initials: CK
authors.lastname: Hsu
authors.forename: C-Y
authors.initials: CY
authors.lastname: Cheng
authors.forename: J-H
authors.initials: JH
authors.lastname: Hung
authors.forename: M L
authors.initials: ML
authors.lastname: Li
authors.forename: F-C
authors.initials: FC
authors.lastname: Huang
authors.forename: W-L
authors.initials: WL
authors.lastname: Yang
authors.forename: J Y-Y
authors.initials: JY
authors.lastname: Lee
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D015355:Glaucoma, Neovascular / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012170:Retinal Vein Occlusion / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab